Daacro   Report issue

For profit
Founded: Trier Germany (2006)

Organization Overview

First Clinical Trial
2017
NCT03353441
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Daacro

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 7